Anoro(R) (Umeclidinium/Vilanterol) Gains Marketing Authorisation in Europe for the Treatment of COPD

[Marketwired] – GlaxoSmithKline plc and Theravance, Inc. today announced that the European Commission has granted marketing authorisation for Anoro® as a once-daily, maintenance bronchodilator treatment to relieve symptoms … more

View todays social media effects on THRX

View the latest stocks trending across Twitter. Click to view dashboard

See who Theravance is hiring next, click here to view